Clinical Trial Update: A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating a targeted estrogen-based therapy (TSEC) for symptom management in menopausal women with multiple sclerosis; results completed and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Multiple Sclerosis

Snippet

Sponsor: University of California, San Francisco | Conditions: Menopause, Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2020-06-29